Sign up to save your podcasts
Or
Share The High Dose Aflibercept DME Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The High Dose Aflibercept DME Trial
We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.
More shows like Retina Synthesis
View all
New Retina Radio by Eyetube
18 Listeners
White Coat Investor Podcast
2,446 Listeners
The Daily
112,617 Listeners
WSJ Minute Briefing
670 Listeners
Up First from NPR
56,456 Listeners
Bogleheads On Investing Podcast
594 Listeners
MedEdTalks - Ophthalmology
4 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
Talking Euretina
1 Listeners
RetinaRounds™
0 Listeners
The Last Invention
707 Listeners